PROTAC(H-PGDS)-7

N/A

Report date: 2023/03/02 16:29:22
NME

Base Information

Drug NamePROTAC(H-PGDS)-7
Drug Alias NamePROTAC(H-PGDS)-7
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProstaglandin-H2 D-isomerase degraders
TargetsProstaglandin-H2 D-isomerase
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYokohama City University
China Registration ClassN/A

Develop Information

Active CompaniesYokohama City University
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A